The Country Health Profiles are an important step in the European Commission’s two-year State of Health in the EU cycle and are the result of joint work between the OECD and the European Observatory on Health Systems and Policies. The concise, policy relevant profiles are based on a transparent, consistent methodology, using both quantitative and qualitative data, yet flexibly adapted to the context of each EU Member State.
English, PDF, 547kb
Belgium shows average health outcomes compared to other OECD countries. Life expectancy at birth is 80.7 years, just above the OECD average. Quality of care is fair, standing again near the OECD average. Health expenditure at 10.2% of GDP is higher than the OECD average of 1.3% points in 2013. Health policy in Belgium relies on shared responsibility of both the federal authorities and federated entities (regions and communities).
Specific country notes have been prepared using data from the database OECD Health Statistics 2015, July 2015 version. The notes are available in PDF format.
The global economic crisis has had a profound impact on people’s well-being, reaching far beyond the loss of jobs and income, and affecting citizens’ satisfaction with their lives and their trust in governments, according to a new OECD report.
Belgium has a good record in delivering accessible care, but adaptation to population ageing will be complicated by the fragmentation of responsibilities in the healthcare system and a strong reliance on government regulations.
Belgian companies, mutualities and employment services should be more proactive in helping people with mental health problems stay in the workplace or find a job, according to a new OECD report.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
English, , 82kb
This working paper provides a preliminary overview of the main hospital administrative data sets potentially available in Australia, Belgium, Canada, Denmark, Finland, France, United Kingdom, Italy, Sweden and the United States.